Year: 2024
Type: article
Abstract: Asthma is a heterogeneous inflammatory disease that affects around 5-10% of children globally. Up to 2% of pediatric asthmatic patients suffer from severe asthma, which leads to increased hospitalizations, higher healthcare costs, and poorer outcomes despite intensive standard treatment. Within this context, the endotype-driven approach and use of biologics have provided significant benefits in treating severe asthma and its associated comorbidities. Additionally, the emerging role of digital health may greatly reduce the global burden of asthma
Institution: Istituto Giannina Gaslini
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4406731563